Author

Jianxin Lin 1

1 Merck & Co., Inc.,Kenilworth,United States

PREDICTORS OF CLINICAL RESPONSE AND INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IMPROVEMENT WITH GOLIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS IN THE PURSUIT-MAINTENANCE STUDY

Alan Meehan, Jianxin Lin, Cindy LJ Weinstein, Marinella Govoni, Zaina P Qureshi

Item 1 - 1 / 1
1